Influenza Immunization at Midlife and the Risk of Parkinson Disease
This cohort study found that influenza immunization at midlife was not associated with the risk of PD in the overall population. Potential benefits for PD risk occurring several years after vaccination or in specific patient subgroups require further investigation.
Authors
- Samy Suissa (ORCID: https://orcid.org/0000-0002-1281-5296)
- Antonios Douros (ORCID: https://orcid.org/0000-0002-6005-4006)
- Paul Brassard (ORCID: https://orcid.org/0000-0001-7485-2546)
- Ying Cui (ORCID: https://orcid.org/0000-0001-7834-7897)
- Sophie Dell’Aniello (ORCID: https://orcid.org/0000-0002-4373-7876)
Institutions
- Jewish General Hospital (CA)
- McGill University (CA)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.47140
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Amgen
- Canadian Institutes of Health Research